Kodiak Sciences (KOD) Operating Expenses (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Operating Expenses came in at $59.8 million in Q1 2026, up 1.19% YoY from $59.1 million in Q1 2025, and up 4.05% on a QoQ basis from $57.5 million in Q4 2025.
Kodiak Sciences (KOD) Operating Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Operating Expenses data on file, last reported at $59.8 million in Q1 2026.
- Quarterly Operating Expenses rose 1.19% year-over-year to $59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $235.1 million (up 17.62% YoY) and the FY2025 annual result came in at $234.4 million, up 25.44% from the prior year.
- Operating Expenses improved to $59.8 million in Q1 2026, from $57.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $95.8 million in Q1 2022 to a low of $46.1 million in Q1 2024.
- A 5-year average of $64.7 million and a median of $59.8 million in 2026 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 89.42% — and 2024, when it slumped 43.44%.
- Tracing KOD's Operating Expenses over 5 years: stood at $74.1 million in 2022, then declined by 14.44% to $63.4 million in 2023, then slipped by 27.13% to $46.2 million in 2024, then advanced by 24.41% to $57.5 million in 2025, then advanced by 4.05% to $59.8 million in 2026.
- The last three Operating Expenses figures came in at $59.8 million (Q1 2026), $57.5 million (Q4 2025), and $62.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 66.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.84 Mn |
| Mar 31, 2026 | 59.78 Mn |
| Dec 31, 2025 | 57.45 Mn |
| Sep 30, 2025 | 62.35 Mn |
| Jun 30, 2025 | 55.51 Mn |
| Mar 31, 2025 | 59.07 Mn |
| Dec 31, 2024 | 46.18 Mn |
| Sep 30, 2024 | 46.63 Mn |
| Jun 30, 2024 | 47.98 Mn |
| Mar 31, 2024 | 46.06 Mn |
| Dec 31, 2023 | 63.37 Mn |
| Sep 30, 2023 | 54.50 Mn |
| Jun 30, 2023 | 84.83 Mn |
| Mar 31, 2023 | 74.62 Mn |
| Dec 31, 2022 | 74.07 Mn |
| Sep 30, 2022 | 79.48 Mn |
| Jun 30, 2022 | 92.07 Mn |
| Mar 31, 2022 | 95.77 Mn |
| Dec 31, 2021 | 93.05 Mn |
| Sep 30, 2021 | 67.54 Mn |